Efficacy News and Research

RSS
Roche's cobas KRAS Mutation Test for colorectal cancer now available in Europe

Roche's cobas KRAS Mutation Test for colorectal cancer now available in Europe

Social safety net programs also reduce childhood obesity

Social safety net programs also reduce childhood obesity

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Australian anti-cancer company completes $2.6 million placement

Australian anti-cancer company completes $2.6 million placement

Neovasc to fund Tiara project with $4 million private placement

Neovasc to fund Tiara project with $4 million private placement

Medco enters definitive merger agreement with Express Scripts

Medco enters definitive merger agreement with Express Scripts

Children and adults with social withdrawal due to Fragile X may benefit from STX209

Children and adults with social withdrawal due to Fragile X may benefit from STX209

Boosted REYATAZ shows durable viral suppression in women with HIV

Boosted REYATAZ shows durable viral suppression in women with HIV

Localized one-time gene therapy might effectively protect against atherosclerosis

Localized one-time gene therapy might effectively protect against atherosclerosis

Intense visual stimulation renders nerve cells more receptive to subsequent learning

Intense visual stimulation renders nerve cells more receptive to subsequent learning

Bristol-Myers Squibb announces results of BMS-708163 Phase II study on Alzheimer's

Bristol-Myers Squibb announces results of BMS-708163 Phase II study on Alzheimer's

New anti-cancer drugs plus chemo for breast cancer shows promise: Study

New anti-cancer drugs plus chemo for breast cancer shows promise: Study

Medco announces new offerings within Advanced Oncology Solutions

Medco announces new offerings within Advanced Oncology Solutions

Chemotherapy combined with anti-cancer agent shows promise for treatment of aggressive breast cancers

Chemotherapy combined with anti-cancer agent shows promise for treatment of aggressive breast cancers

Clinipace Worldwide selected to manage Spectranetics' cardiovascular device clinical study

Clinipace Worldwide selected to manage Spectranetics' cardiovascular device clinical study

Investigational compound dapagliflozin receives negative recommendation from FDA Advisory Committee

Investigational compound dapagliflozin receives negative recommendation from FDA Advisory Committee

Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference

Janssen presents EDURANT 96-week Phase 3 trial data at International AIDS Society Conference

Possible new drug targets for treating diffuse large B-cell lymphoma

Possible new drug targets for treating diffuse large B-cell lymphoma

Convergence initiates CNV1014802 Phase II study in lumbosacral radiculopathy

Convergence initiates CNV1014802 Phase II study in lumbosacral radiculopathy

Anti-malaria drug provides key insight into potential treatments for autoimmune diseases

Anti-malaria drug provides key insight into potential treatments for autoimmune diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.